# Public Service Enterprise Group Inc: financial statements, quarterly

PEG · NYSE · CIK 788784 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/peg.md) · [Financials](/companies/peg/financials.md) · [Filings](/companies/peg/filings.md) · [Insiders](/companies/peg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/peg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,456](/filings/0000950170-24-120749.md) | [2,605 d](/filings/0001193125-26-077446.md) | [2,760](/filings/0000950170-25-061108.md) | [2,423](/filings/0000950170-25-103096.md) | [2,642](/filings/0001193125-25-262643.md) | [2,465 d](/filings/0001193125-26-077446.md) | [3,222](/filings/0001193125-26-206545.md) | [2,805](/filings/0001193125-26-332943.md) | [3,226](/filings/0001193125-25-262643.md) | [2,915 d](/filings/0001193125-26-077446.md) | [3,848](/filings/0001193125-26-206545.md) | [2,554](/filings/0001193125-26-332943.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [551](/filings/0000950170-24-120749.md) | [692 d](/filings/0001193125-26-077446.md) | [685](/filings/0000950170-25-061108.md) | [582](/filings/0000950170-25-103096.md) | [641](/filings/0001193125-25-262643.md) | [445 d](/filings/0001193125-26-077446.md) | [797](/filings/0001193125-26-206545.md) | [817](/filings/0001193125-26-332943.md) | [855](/filings/0001193125-25-262643.md) | [511 d](/filings/0001193125-26-077446.md) | [1,075](/filings/0001193125-26-206545.md) | [461](/filings/0001193125-26-332943.md) |
| Interest expense | $m | [185](/filings/0000950170-24-120749.md) | [198 d](/filings/0001193125-26-077446.md) | [205](/filings/0000950170-25-061108.md) | [218](/filings/0000950170-25-103096.md) | [227](/filings/0001193125-25-262643.md) | [232 d](/filings/0001193125-26-077446.md) | [241](/filings/0001193125-26-206545.md) | [248](/filings/0001193125-26-332943.md) | [253](/filings/0001193125-25-262643.md) | [263 d](/filings/0001193125-26-077446.md) | [272](/filings/0001193125-26-206545.md) | [269](/filings/0001193125-26-332943.md) |
| Income tax | $m | [(74.0)](/filings/0000950170-24-120749.md) | [141 d](/filings/0001193125-26-077446.md) | [97.0](/filings/0000950170-25-061108.md) | [3.0](/filings/0000950170-25-103096.md) | [39.0](/filings/0001193125-25-262643.md) | [(86.0) d](/filings/0001193125-26-077446.md) | [28.0](/filings/0001193125-26-206545.md) | [141](/filings/0001193125-26-332943.md) | [98.0](/filings/0001193125-25-262643.md) | [(4.0) d](/filings/0001193125-26-077446.md) | [107](/filings/0001193125-26-206545.md) | [64.0](/filings/0001193125-26-332943.md) |
| Net income | $m | [139](/filings/0000950170-24-120749.md) | [546 d](/filings/0001193125-26-077446.md) | [532](/filings/0000950170-25-061108.md) | [434](/filings/0000950170-25-103096.md) | [520](/filings/0001193125-25-262643.md) | [286 d](/filings/0001193125-26-077446.md) | [589](/filings/0001193125-26-206545.md) | [585](/filings/0001193125-26-332943.md) | [622](/filings/0001193125-25-262643.md) | [315 d](/filings/0001193125-26-077446.md) | [741](/filings/0001193125-26-206545.md) | [334](/filings/0001193125-26-332943.md) |
| Diluted EPS | $ per share | [0.27](/filings/0000950170-24-120749.md) | not reported | [1.06](/filings/0000950170-25-061108.md) | [0.87](/filings/0000950170-25-103096.md) | [1.04](/filings/0001193125-25-262643.md) | not reported | [1.18](/filings/0001193125-26-206545.md) | [1.17](/filings/0001193125-26-332943.md) | [1.24](/filings/0001193125-25-262643.md) | not reported | [1.48](/filings/0001193125-26-206545.md) | [0.67](/filings/0001193125-26-332943.md) |
| Basic EPS | $ per share | [0.28](/filings/0000950170-24-120749.md) | not reported | [1.07](/filings/0000950170-25-061108.md) | [0.87](/filings/0000950170-25-103096.md) | [1.04](/filings/0001193125-25-262643.md) | not reported | [1.18](/filings/0001193125-26-206545.md) | [1.17](/filings/0001193125-26-332943.md) | [1.25](/filings/0001193125-25-262643.md) | not reported | [1.48](/filings/0001193125-26-206545.md) | [0.67](/filings/0001193125-26-332943.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0000788784-23-000008.md) | [0.1](/filings/0000950170-25-026874.md) | [1.2](/filings/0001628280-24-019352.md) | [0.1](/filings/0001628280-24-033496.md) | [0.2](/filings/0000950170-24-120749.md) | [0.1](/filings/0001193125-26-077446.md) | [0.9](/filings/0000950170-25-061108.md) | [0.2](/filings/0000950170-25-103096.md) | [0.3](/filings/0001193125-25-262643.md) | [0.1](/filings/0001193125-26-332943.md) | [0.4](/filings/0001193125-26-206545.md) | [0.2](/filings/0001193125-26-332943.md) |
| Current assets | $bn | [3.3](/filings/0000788784-23-000008.md) | [3.4](/filings/0000950170-25-026874.md) | [4.3](/filings/0001628280-24-019352.md) | [3.6](/filings/0001628280-24-033496.md) | [4.0](/filings/0000950170-24-120749.md) | [4.2](/filings/0001193125-26-077446.md) | [4.8](/filings/0000950170-25-061108.md) | [4.6](/filings/0000950170-25-103096.md) | [4.7](/filings/0001193125-25-262643.md) | [4.6](/filings/0001193125-26-332943.md) | [4.4](/filings/0001193125-26-206545.md) | [4.6](/filings/0001193125-26-332943.md) |
| Total assets | $bn | [49.6](/filings/0000788784-23-000008.md) | [50.7](/filings/0001193125-26-077446.md) | [52.4](/filings/0001628280-24-019352.md) | [52.4](/filings/0001628280-24-033496.md) | [54.1](/filings/0000950170-24-120749.md) | [54.6](/filings/0001193125-26-077446.md) | [55.6](/filings/0000950170-25-061108.md) | [56.0](/filings/0000950170-25-103096.md) | [56.9](/filings/0001193125-25-262643.md) | [57.6](/filings/0001193125-26-332943.md) | [57.9](/filings/0001193125-26-206545.md) | [58.8](/filings/0001193125-26-332943.md) |
| Current liabilities | $bn | [5.2](/filings/0000788784-23-000008.md) | [5.1](/filings/0000950170-25-026874.md) | [5.4](/filings/0001628280-24-019352.md) | [5.5](/filings/0001628280-24-033496.md) | [5.9](/filings/0000950170-24-120749.md) | [6.5](/filings/0001193125-26-077446.md) | [5.8](/filings/0000950170-25-061108.md) | [4.6](/filings/0000950170-25-103096.md) | [5.0](/filings/0001193125-25-262643.md) | [5.7](/filings/0001193125-26-332943.md) | [4.6](/filings/0001193125-26-206545.md) | [5.2](/filings/0001193125-26-332943.md) |
| Long-term debt | $bn | [17.0](/filings/0000788784-23-000008.md) | [17.8](/filings/0000950170-25-026874.md) | [18.8](/filings/0001628280-24-019352.md) | [18.4](/filings/0001628280-24-033496.md) | [19.0](/filings/0000950170-24-120749.md) | [19.0](/filings/0001193125-26-077446.md) | [20.4](/filings/0000950170-25-061108.md) | [21.6](/filings/0000950170-25-103096.md) | [21.7](/filings/0001193125-25-262643.md) | [21.7](/filings/0001193125-26-332943.md) | [22.7](/filings/0001193125-26-206545.md) | [22.7](/filings/0001193125-26-332943.md) |
| Current portion of debt | $bn | [2.0](/filings/0000788784-23-000008.md) | [1.5](/filings/0000950170-25-026874.md) | [2.5](/filings/0001628280-24-019352.md) | [2.1](/filings/0001628280-24-033496.md) | [2.4](/filings/0000950170-24-120749.md) | [2.2](/filings/0001193125-26-077446.md) | [2.6](/filings/0000950170-25-061108.md) | [1.0](/filings/0000950170-25-103096.md) | [0.9](/filings/0001193125-25-262643.md) | [0.9](/filings/0001193125-26-332943.md) | [0.4](/filings/0001193125-26-206545.md) | [0.9](/filings/0001193125-26-332943.md) |
| Short-term borrowings | $bn | [0.7](/filings/0000788784-23-000008.md) | [0.9](/filings/0000950170-25-026874.md) | [0.5](/filings/0001628280-24-019352.md) | [0.9](/filings/0001628280-24-033496.md) | [0.5](/filings/0000950170-24-120749.md) | [1.6](/filings/0001193125-26-077446.md) | [0.4](/filings/0000950170-25-061108.md) | [0.7](/filings/0000950170-25-103096.md) | [0.8](/filings/0001193125-25-262643.md) | [1.5](/filings/0001193125-26-332943.md) | [1.2](/filings/0001193125-26-206545.md) | [1.0](/filings/0001193125-26-332943.md) |
| Shareholders' equity | $bn | [15.2](/filings/0000950170-24-120749.md) | [15.5](/filings/0001193125-26-077446.md) | [15.7](/filings/0000950170-25-103096.md) | [15.8](/filings/0001193125-25-262643.md) | [16.1](/filings/0001193125-25-262643.md) | [16.1](/filings/0001193125-26-332943.md) | [16.4](/filings/0001193125-26-332943.md) | [16.7](/filings/0001193125-26-332943.md) | [17.0](/filings/0001193125-25-262643.md) | [17.0](/filings/0001193125-26-332943.md) | [17.3](/filings/0001193125-26-332943.md) | [17.3](/filings/0001193125-26-332943.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [687 d](/filings/0000950170-24-120749.md) | [710 d](/filings/0001193125-26-077446.md) | [661](/filings/0000950170-25-061108.md) | [482 d](/filings/0000950170-25-103096.md) | [623 d](/filings/0001193125-25-262643.md) | [367 d](/filings/0001193125-26-077446.md) | [1,049](/filings/0001193125-26-206545.md) | [478 d](/filings/0001193125-26-332943.md) | [1,050 d](/filings/0001193125-25-262643.md) | [721 d](/filings/0001193125-26-077446.md) | [1,271](/filings/0001193125-26-206545.md) | [550 d](/filings/0001193125-26-332943.md) |
| Capital expenditure | $m | [916 d](/filings/0000950170-24-120749.md) | [965 d](/filings/0001193125-26-077446.md) | [797](/filings/0000950170-25-061108.md) | [837 d](/filings/0000950170-25-103096.md) | [768 d](/filings/0001193125-25-262643.md) | [978 d](/filings/0001193125-26-077446.md) | [628](/filings/0001193125-26-206545.md) | [787 d](/filings/0001193125-26-332943.md) | [728 d](/filings/0001193125-25-262643.md) | [1,129 d](/filings/0001193125-26-077446.md) | [693](/filings/0001193125-26-206545.md) | [766 d](/filings/0001193125-26-332943.md) |
| Dividends paid | $m | [284](/filings/0000950170-24-120749.md) | [284 d](/filings/0001193125-26-077446.md) | [299](/filings/0000950170-25-061108.md) | [299](/filings/0000950170-25-103096.md) | [299](/filings/0001193125-25-262643.md) | [299 d](/filings/0001193125-26-077446.md) | [314](/filings/0001193125-26-206545.md) | [315](/filings/0001193125-26-332943.md) | [314](/filings/0001193125-25-262643.md) | [315 d](/filings/0001193125-26-077446.md) | [334](/filings/0001193125-26-206545.md) | [334](/filings/0001193125-26-332943.md) |
| Share repurchases | $m | [0.0 d](/filings/0000788784-23-000008.md) | [0.0 d](/filings/0000950170-25-026874.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [500](/filings/0000788784-23-000008.md) | [500](/filings/0001628280-24-019352.md) | [500](/filings/0001628280-24-033496.md) | [500](/filings/0000950170-24-120749.md) | [500](/filings/0000950170-25-061108.md) | [500](/filings/0000950170-25-103096.md) | [500](/filings/0001193125-25-262643.md) | [500](/filings/0001193125-26-206545.md) | [500](/filings/0001193125-26-332943.md) | [501](/filings/0001193125-25-262643.md) | [500](/filings/0001193125-26-206545.md) | [499](/filings/0001193125-26-332943.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 498,420,030 at 2026-07-20, from the cover of the [10-Q filed 2026-08-04](/filings/0001193125-26-332943.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.